Drug Resistance Factors In Healthcare-associated Pneumonia

NCT02736097 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 679

Last updated 2017-08-01

No results posted yet for this study

Summary

Recently clinical guidelines categorize pneumonia in to three types: community, healthcare-associated, and hospital-acquired. Much of the existing research to describe the epidemiology of pneumonia in critically ill patients comes from single-center studies or from retrospective database analyses, which limit generalizability and lead to over-prescription of broad-spectrum antibacterial agents. This will be a prospective, multicenter epidemiological study to characterize pneumonia epidemiology in critically ill adult patients.

Conditions

Sponsors & Collaborators

  • University of Arkansas

    collaborator OTHER
  • Critical Care Pharmacotherapy Trials Network

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-01-31
Completion
2017-02-28

Countries

  • United States
  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02736097 on ClinicalTrials.gov